Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,846 | 2,238 | 1,008 | 934 | 2,784 |
| Receivables | 71 | 86 | 161 | 169 | 143 |
| Inventories | 238 | 421 | 217 | 229 | 243 |
| Other current assets | 41 | 39 | 39 | 39 | 39 |
| TOTAL | $14,050 | $3,972 | $2,088 | $2,097 | $3,958 |
| Non-Current Assets | |||||
| PPE Net | 54 | 57 | 60 | 61 | 14 |
| Other Non-Current Assets | 84 | 103 | 114 | 128 | 142 |
| TOTAL | $138 | $160 | $174 | $189 | $155 |
| Total Assets | $14,188 | $4,132 | $2,262 | $2,286 | $4,113 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 87 | 61 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,541 | 4,458 | 3,979 | 3,936 | 3,125 |
| TOTAL | $3,673 | $4,560 | $4,057 | $3,952 | $3,141 |
| Non-Current Liabilities | |||||
| Long Term Debt | 45 | 71 | 98 | N/A | N/A |
| Other Non-Current Liabilities | 18 | 26 | 28 | 32 | 36 |
| TOTAL | $63 | $97 | $125 | $32 | $36 |
| Total Liabilities | $3,736 | $4,657 | $4,182 | $3,984 | $3,177 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,293 | 1,700 | 1,417 | 1,417 | 1,217 |
| Common Shares | 1 | 17 | 14 | 12 | 0 |
| Retained earnings | -34,062 | -31,382 | -29,947 | -27,754 | -25,120 |
| TOTAL | $10,453 | $-525 | $-1,920 | $-1,698 | $936 |
| Total Liabilities And Equity | $14,188 | $4,133 | $2,262 | $2,286 | $4,113 |